4//SEC Filing
Auster Martin 4
Accession 0001209191-23-059222
CIK 0001851194other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:21 PM ET
Size
5.8 KB
Accession
0001209191-23-059222
Insider Transaction Report
Form 4
Auster Martin
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-18+181,250→ 181,250 totalExercise: $2.14Exp: 2033-12-18→ Common Stock (181,250 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following December 18, 2023 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider, as defined in the Company's 2021 Equity Incentive Plan (the "Plan") through each such date.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001875786
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:21 PM ET
- Size
- 5.8 KB